Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system.
Saved in:
| Title: | Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system. |
|---|---|
| Authors: | Lin W; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China., Xu J; School of Pharmaceutical, Fujian University of Traditional Chinese Medicine, Fuzhou, China., Liao Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China., Lin X; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China., Yang J; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China., Zhuang W; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China. zhuangwei1333@gmail.com. |
| Source: | International journal of clinical pharmacy [Int J Clin Pharm] 2024 Jun; Vol. 46 (3), pp. 776. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
